BACKGROUND: The purpose of this study was to present the establishment of new cell lines, which is important to cancer research. METHODS: Six new head and neck squamous cell carcinoma cell lines were established using a novel fluorescence-activated cell sorting (FACS) method in order to overcome the barrier of fibroblast overgrowth and the susceptibility of primary tumors to fail in vitro. RESULTS: Antibodies chosen for specific targeting of epithelial cells and fibroblasts successfully separated cells for line establishment in 6 of 12 attempts, providing an alternative method of establishing head and neck squamous cell carcinoma cell lines. Each attempt at cell line establishment resulted in an epithelial carcinoma population, which was genotyped and catalogued as a unique cell line, and a corresponding fibroblast population. CONCLUSION: The selection of antibody markers could be optimized to aid in the establishment of any cancer cell line derived from any tumor tissue; this method is not limited to head and neck cancer.
BACKGROUND: The purpose of this study was to present the establishment of new cell lines, which is important to cancer research. METHODS: Six new head and neck squamous cell carcinoma cell lines were established using a novel fluorescence-activated cell sorting (FACS) method in order to overcome the barrier of fibroblast overgrowth and the susceptibility of primary tumors to fail in vitro. RESULTS: Antibodies chosen for specific targeting of epithelial cells and fibroblasts successfully separated cells for line establishment in 6 of 12 attempts, providing an alternative method of establishing head and neck squamous cell carcinoma cell lines. Each attempt at cell line establishment resulted in an epithelial carcinoma population, which was genotyped and catalogued as a unique cell line, and a corresponding fibroblast population. CONCLUSION: The selection of antibody markers could be optimized to aid in the establishment of any cancer cell line derived from any tumor tissue; this method is not limited to head and neck cancer.
Authors: Samuel Y Boateng; Thomas J Hartman; Neil Ahluwalia; Himabindu Vidula; Tejal A Desai; Brenda Russell Journal: Am J Physiol Cell Physiol Date: 2003-04-02 Impact factor: 4.249
Authors: Brett Hall; Jennifer Dembinski; A Kate Sasser; Matus Studeny; Michael Andreeff; Frank Marini Journal: Int J Hematol Date: 2007-07 Impact factor: 2.490
Authors: Daniel J Liebertz; Melissa G Lechner; Rizwan Masood; Uttam K Sinha; Jing Han; Raj K Puri; Adrian J Correa; Alan L Epstein Journal: Head Neck Oncol Date: 2010-02-22
Authors: J Chad Brenner; Martin P Graham; Bhavna Kumar; Lindsay M Saunders; Robbi Kupfer; Robert H Lyons; Carol R Bradford; Thomas E Carey Journal: Head Neck Date: 2010-04 Impact factor: 3.147
Authors: Giacomo Miserocchi; Chiara Spadazzi; Sebastiano Calpona; Francesco De Rosa; Alice Usai; Alessandro De Vita; Chiara Liverani; Claudia Cocchi; Silvia Vanni; Chiara Calabrese; Massimo Bassi; Giovanni De Luca; Giuseppe Meccariello; Toni Ibrahim; Marco Schiavone; Laura Mercatali Journal: J Pers Med Date: 2022-05-24
Authors: John Henry Owen; Christine M Komarck; Anthony C Wang; Waleed M Abuzeid; Richard F Keep; Erin L McKean; Stephen Sullivan; Xing Fan; Mark E P Prince Journal: J Neurosurg Date: 2017-04-21 Impact factor: 5.115
Authors: Amy J C Dohmen; Justin E Swartz; Michiel W M Van Den Brekel; Stefan M Willems; René Spijker; Jacques Neefjes; Charlotte L Zuur Journal: Cancers (Basel) Date: 2015-08-28 Impact factor: 6.639